Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07372950 · ClinicalTrials.gov registry record · NA

Kaiser Colorado Flu Nudge

A NA study of Influenza and Vaccination, sponsored by Kaiser Permanente.

Active
Registry status
NA
Development phase
100,000
Enrollment target
1
Study location

NCT07372950: Active NA study of Influenza and Vaccination, sponsored by Kaiser Permanente.

NCT07372950 is a NA study of Influenza and Vaccination that is active but no longer recruiting, run by Kaiser Permanente. The registered enrollment target is 100,000 participants, above the 36,163-participant average among 156 other Influenza trials with a reported enrollment target (177% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07372950, a NA study of Influenza and Vaccination, is active but no longer recruiting, sponsored by Kaiser Permanente.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
100,000 participants
Enrollment target
1
Study location

Study Summary

Influenza infection leads to significant morbidity and mortality each year. Influenza vaccines can reduce the risk of flu and the severity of flu illness, In addition, flu vaccinations can reduce flu complications such as pneumonia or worsening of chronic heart or lung disease. Each year, Kaiser Permanente of Colorado offers influenza vaccines to patients at no cost either at primary care clinic appointments or flu walk-in clinics in the fall prior to the upcoming flu season. In addition, as part of clinic appointment reminder text messages, there is a message to get the flu vaccine for patients who have not received the vaccine prior to the clinic visit. Building on these flu reminder text messages for patients who have not received a flu vaccine, this study will test different behavioral nudge text messages to improve influenza vaccination rates.

Primary Outcome

Did the patient receive a flu vaccine as denoted from the EMR. The vaccine could have occurred within Kaiser Permanente Colorado or outside of Kaiser Permanente Colorado and in which Kaiser received information about the flu vaccination during the flu season 2025-2026.

Conditions Studied

Interventions

  • BEHAVIORAL Behavioral economics framed test messaging

Study Locations (1)

Colorado

  • Institute for Health Research - Aurora

Trial Details

FieldValue
Enrollment Target 100,000 participants
Start Date 2025-10-06
Est. Completion 2026-09-01
Phase NA
Kaiser Permanente

294 total trials

What the registry record for NCT07372950 still lists

NCT07372950 is an interventional study that assigns participants to a tested intervention. Its 100,000 participants enrollment target places it among the larger protocols in the corpus, above the 36,163-participant average among 156 other Influenza trials with a reported enrollment target (177% higher).

The record links to 2 conditions, with Influenza appearing as the primary indexed condition, and to 1 intervention - of which Behavioral economics framed test messaging is the first listed.

NCT07372950 reports a single indexed study location in Colorado.

Frequently Asked Questions

What is clinical trial NCT07372950 about?

NCT07372950 is a clinical study titled "Kaiser Colorado Flu Nudge". Influenza infection leads to significant morbidity and mortality each year. Influenza vaccines can reduce the risk of flu and the severity of flu illness, In addition, flu vaccinations can reduce flu complications such as pneumonia or worsening of chronic heart or lung disease. Each year, Kaiser Per...

What is the current status of trial NCT07372950?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 100,000 participants. The study started on 2025-10-06. Estimated completion is 2026-09-01.

What conditions does trial NCT07372950 study?

This clinical trial studies the following conditions: Influenza, Vaccination.

What interventions are being tested in trial NCT07372950?

The interventions under investigation include: Behavioral economics framed test messaging (BEHAVIORAL).

Who is sponsoring clinical trial NCT07372950?

This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07372950 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Influenza

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07372950's enrollment target sits among peer trials

100,000 5th of 156 higher than 151 of 156 other Influenza trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Influenza trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02620852 · 100,000 participants · NA

    Women Informed to Screen Depending on Measures of Risk (Wisdom Study)

  • NCT03277365 · 100,000 participants · NA

    MyGeneRank: A Digital Platform for Next-Generation Genetic Studies

  • NCT04281823 · 100,000 participants

    DeBakey Cardiovascular Magnetic Resonance Study

  • NCT04869111 · 100,000 participants · NA

    The BrainHealth Project

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07372950, the US trial registry maintained by the National Library of Medicine. NCT07372950 (large enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.